Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3411

1.

A new species of the mud shrimp genus Axianassa Schmitt, 1924 (Decapoda: Gebiidea: Laomediidae) from the Ryukyu Islands, southern Japan.

Komai T, Fujita Y.

Zootaxa. 2019 Aug 23;4658(3):zootaxa.4658.3.2. doi: 10.11646/zootaxa.4658.3.2.

PMID:
31716730
2.

Submarine cave hermit crabs (Crustacea: Decapoda: Anomura: Paguroidea) from three islands of the Ryukyu Islands, southwestern Japan.

Osawa M, Fujita Y.

Zootaxa. 2019 Feb 26;4560(3):zootaxa.4560.3.3. doi: 10.11646/zootaxa.4560.3.3.

PMID:
31716567
4.

Effect of preventive closure of the frenulum after endoscopic papillectomy: a prospective pilot study.

Kagawa K, Kubota K, Kurita Y, Takagi Y, Ishii K, Hasegawa S, Iwasaki A, Sato T, Fujita Y, Kato S, Watanabe S, Sekino Y, Hosono K, Nakajima A.

J Gastroenterol Hepatol. 2019 Nov 6. doi: 10.1111/jgh.14922. [Epub ahead of print]

PMID:
31693767
5.

Super-activator variants of the cyanobacterial transcriptional regulator ChlR essential for tetrapyrrole biosynthesis under low oxygen conditions.

Hiraide Y, Yamamoto H, Kawajiri Y, Yamakawa H, Wada K, Fujita Y.

Biosci Biotechnol Biochem. 2019 Nov 6:1-10. doi: 10.1080/09168451.2019.1687281. [Epub ahead of print]

PMID:
31690227
6.

High Serum Cortisol Levels as a Potential Indicator for Changes in Well-Regulated Daily Life among Junior High School Students.

Inoue K, Hashioka S, Takeshita H, Kamura M, Fujita Y.

Tohoku J Exp Med. 2019 Nov;249(3):143-146. doi: 10.1620/tjem.249.143.

7.

Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.

Hosomi Y, Morita S, Sugawara S, Kato T, Fukuhara T, Gemma A, Takahashi K, Fujita Y, Harada T, Minato K, Takamura K, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group.

J Clin Oncol. 2019 Nov 4:JCO1901488. doi: 10.1200/JCO.19.01488. [Epub ahead of print]

PMID:
31682542
8.

Microvascular density under magnifying narrow-band imaging endoscopy in colorectal epithelial neoplasms.

Gonai T, Kawasaki K, Nakamura S, Yanai S, Akasaka R, Sato K, Toya Y, Asakura K, Urushikubo J, Fujita Y, Eizuka M, Uesugi N, Sugai T, Matsumoto T.

Intest Res. 2019 Nov 4. doi: 10.5217/ir.2019.00061. [Epub ahead of print]

9.

Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.

Iwama E, Goto Y, Murakami H, Tsumura S, Sakashita H, Mori Y, Nakagaki N, Fujita Y, Seike M, Bessho A, Ono M, Nishitsuji M, Akamatsu H, Morinaga R, Akagi T, Shimose T, Tokunaga S, Yamamoto N, Nakanishi Y, Sugio K, Okamoto I.

Oncologist. 2019 Oct 30. pii: theoncologist.2019-0728. doi: 10.1634/theoncologist.2019-0728. [Epub ahead of print]

PMID:
31666370
10.

A prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302).

Asahina H, Oizumi S, Takamura K, Harada T, Harada M, Yokouchi H, Kanazawa K, Fujita Y, Kojima T, Sugaya F, Tanaka H, Honda R, Kikuchi E, Ikari T, Ogi T, Shimizu K, Suzuki M, Konno S, Dosaka-Akita H, Isobe H, Nishimura M; Hokkaido Lung Cancer Clinical Study Group.

Lung Cancer. 2019 Sep 30;138:65-71. doi: 10.1016/j.lungcan.2019.09.020. [Epub ahead of print]

PMID:
31654836
11.

Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Tsuchiya-Kawano Y, Sasaki T, Yamaguchi H, Hirano K, Horiike A, Satouchi M, Hosokawa S, Morinaga R, Komiya K, Inoue K, Fujita Y, Toyozawa R, Kimura T, Takahashi K, Nishikawa K, Kishimoto J, Nakanishi Y, Okamoto I.

Oncologist. 2019 Oct 24. pii: theoncologist.2019-0746. doi: 10.1634/theoncologist.2019-0746. [Epub ahead of print]

PMID:
31649134
12.

Pathogenesis of Anti-PIT-1 Antibody Syndrome: PIT-1 Presentation by HLA Class I on Anterior Pituitary Cells.

Kanie K, Bando H, Iguchi G, Muguruma K, Matsumoto R, Hidaka-Takeno R, Okimura Y, Yamamoto M, Fujita Y, Fukuoka H, Yoshida K, Suda K, Nishizawa H, Ogawa W, Takahashi Y.

J Endocr Soc. 2019 Aug 26;3(11):1969-1978. doi: 10.1210/js.2019-00243. eCollection 2019 Nov 1.

13.

Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.

Fujita Y, Doi Y, Hamano T, Hatazaki M, Umayahara Y, Isaka Y, Tsubakihara Y.

Sci Rep. 2019 Oct 16;9(1):14871. doi: 10.1038/s41598-019-51207-8.

14.

Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test.

Takeda Y, Fujita Y, Bessho R, Sato M, Abe T, Yanagimachi T, Sakagami H, Abiko A, Takiyama Y, Ota T, Haneda M.

BMC Endocr Disord. 2019 Oct 15;19(1):99. doi: 10.1186/s12902-019-0428-6.

15.

Modified Submental Island Flap for the Surgical Treatment of 4 Patients With Stage 3 Medication-Related Osteonecrosis of the Mandible.

Myoken Y, Fujita Y, Okamoto T.

J Oral Maxillofac Surg. 2019 Sep 14. pii: S0278-2391(19)31073-0. doi: 10.1016/j.joms.2019.08.028. [Epub ahead of print]

PMID:
31600490
16.

Clinical practice guidelines for the management of atopic dermatitis 2018.

Katoh N, Ohya Y, Ikeda M, Ebihara T, Katayama I, Saeki H, Shimojo N, Tanaka A, Nakahara T, Nagao M, Hide M, Fujita Y, Fujisawa T, Futamura M, Masuda K, Murota H, Yamamoto-Hanada K.

J Dermatol. 2019 Oct 9. doi: 10.1111/1346-8138.15090. [Epub ahead of print]

PMID:
31599013
17.
18.

Assessment of prognosis in immunoglobulin light chain amyloidosis patients with severe heart failure: a predictive value of right ventricular function.

Nagano N, Yano T, Fujita Y, Kouzu H, Koyama M, Ikeda H, Yasui K, Muranaka A, Nishikawa R, Takahashi R, Kishiue N, Yuda S, Miura T.

Heart Vessels. 2019 Sep 26. doi: 10.1007/s00380-019-01513-y. [Epub ahead of print]

PMID:
31559459
19.

Muraminomicins, novel ester derivatives: in vitro and in vivo antistaphylococcal activity.

Kagoshima Y, Tokumitsu A, Masuda T, Namba E, Inoue H, Sugihara C, Yokoyama M, Yamamoto Y, Suzuki K, Iida K, Tamura A, Fujita Y, Takatsu T, Konosu T, Koga T.

J Antibiot (Tokyo). 2019 Sep 27. doi: 10.1038/s41429-019-0235-3. [Epub ahead of print]

PMID:
31558775
20.

Relationship Between Intermittent Hypoxia and Type 2 Diabetes in Sleep Apnea Syndrome.

Ota H, Fujita Y, Yamauchi M, Muro S, Kimura H, Takasawa S.

Int J Mol Sci. 2019 Sep 25;20(19). pii: E4756. doi: 10.3390/ijms20194756. Review.

21.

Update on the efficacy and safety of sodium-glucose cotransporter 2 inhibitors in Asians and non-Asians.

Fujita Y, Inagaki N.

J Diabetes Investig. 2019 Nov;10(6):1408-1410. doi: 10.1111/jdi.13150. Epub 2019 Oct 14. No abstract available.

22.

Gastric cancer during pregnancy with placental involvement: case report and review of published works.

Oga S, Hachisuga M, Hidaka N, Fujita Y, Tomonobe H, Yamamoto H, Kato K.

Obstet Gynecol Sci. 2019 Sep;62(5):357-361. doi: 10.5468/ogs.2019.62.5.357. Epub 2019 Jul 22.

23.

Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis.

Tsubouchi K, Araya J, Yoshida M, Sakamoto T, Koumura T, Minagawa S, Hara H, Hosaka Y, Ichikawa A, Saito N, Kadota T, Kurita Y, Kobayashi K, Ito S, Fujita Y, Utsumi H, Hashimoto M, Wakui H, Numata T, Kaneko Y, Mori S, Asano H, Matsudaira H, Ohtsuka T, Nakayama K, Nakanishi Y, Imai H, Kuwano K.

J Immunol. 2019 Oct 15;203(8):2076-2087. doi: 10.4049/jimmunol.1801232. Epub 2019 Sep 18.

PMID:
31534007
24.

Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress.

Zhang K, Fujita Y, Chang L, Qu Y, Pu Y, Wang S, Shirayama Y, Hashimoto K.

Transl Psychiatry. 2019 Sep 17;9(1):231. doi: 10.1038/s41398-019-0571-x.

25.

Clinical and immune profiling for cancer of unknown primary site.

Haratani K, Hayashi H, Takahama T, Nakamura Y, Tomida S, Yoshida T, Chiba Y, Sawada T, Sakai K, Fujita Y, Togashi Y, Tanizaki J, Kawakami H, Ito A, Nishio K, Nakagawa K.

J Immunother Cancer. 2019 Sep 13;7(1):251. doi: 10.1186/s40425-019-0720-z.

26.

Electron Microscopic and Immunohistochemical Findings of the Epidermal Basement Membrane in Two Families with Nail-patella Syndrome.

Shinkuma S, Nakamura H, Maehara M, Takashima S, Nomura T, Fujita Y, Hasegawa S, Sato-Matsumura KC, Abe R, Shimizu H.

Acta Derm Venereol. 2019 Sep 12. doi: 10.2340/00015555-3318. [Epub ahead of print]

27.

One-year clinical evaluation of rotationally asymmetric multifocal intraocular lens with +1.5 diopters near addition.

Oshika T, Arai H, Fujita Y, Inamura M, Inoue Y, Noda T, Miyata K.

Sci Rep. 2019 Sep 11;9(1):13117. doi: 10.1038/s41598-019-49524-z.

28.

Water-mediated polyol synthesis of pencil-like sharp silver nanowires suitable for nonlinear plasmonics.

Inose T, Toyouchi S, Lu G, Umemoto K, Tezuka Y, Lyu B, Masuhara A, Fron E, Fujita Y, Hirai K, Uji-I H.

Chem Commun (Camb). 2019 Sep 24;55(77):11630-11633. doi: 10.1039/c9cc04743c.

PMID:
31506656
29.

Reliability and validity of on-road driving tests in vulnerable adults: a systematic review.

Sawada T, Tomori K, Hamana H, Ohno K, Seike Y, Igari Y, Fujita Y.

Int J Rehabil Res. 2019 Dec;42(4):289-299. doi: 10.1097/MRR.0000000000000374.

PMID:
31469673
30.

Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.

Matsuoka N, Kozuru H, Koga T, Abiru S, Yamasaki K, Komori A, Fujita Y, Tenmoku J, Asano T, Sato S, Suzuki E, Furuya M, Kobayashi H, Watanabe H, Naganuma A, Yoshizawa K, Shimada M, Ario K, Yamashita H, Kohno H, Kaneyoshi T, Nakamura M, Furukawa H, Takahashi A, Kawakami A, Ohira H, Yatsuhashi H, Migita K.

Medicine (Baltimore). 2019 Aug;98(35):e16924. doi: 10.1097/MD.0000000000016924.

31.

The Effects of Leptin on Glial Cells in Neurological Diseases.

Fujita Y, Yamashita T.

Front Neurosci. 2019 Aug 7;13:828. doi: 10.3389/fnins.2019.00828. eCollection 2019. Review.

32.

[Efficient Commissioning of the Radiotherapy Treatment Planning System with the Golden Beam Data].

Hiroki T, Fujita Y, Maehira S, Soda K, Kikuchi T, Kunieda E.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(8):725-735. doi: 10.6009/jjrt.2019_JSRT_75.8.725. Japanese.

33.

Systemic expression of Alu RNA in patients with geographic atrophy secondary to age-related macular degeneration.

Yoshida H, Matsushita T, Kimura E, Fujita Y, Keany R, Ikeda T, Toshimori M, Imanaka T, Nakamura M.

PLoS One. 2019 Aug 19;14(8):e0220887. doi: 10.1371/journal.pone.0220887. eCollection 2019.

34.

Clinical usefulness of scales for evaluating cognitive impairment in patients with amyotrophic lateral sclerosis.

Nagashima K, Makioka K, Fujita Y, Ikeda M, Ikeda Y.

J Neurol Sci. 2019 Oct 15;405:116414. doi: 10.1016/j.jns.2019.07.032. Epub 2019 Jul 31.

PMID:
31419623
35.

MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.

Fujita A, Fujita Y, Pu Y, Chang L, Hashimoto K.

Psychopharmacology (Berl). 2019 Aug 15. doi: 10.1007/s00213-019-05346-5. [Epub ahead of print]

PMID:
31418048
36.

Response to "Is grip strength an actual/significant predictor of areal bone mineral density by itself? Potential confounders and/or effect modifiers".

Tachiki T, Kouda K, Dongmei N, Tamaki J, Iki M, Kitagawa J, Takahira N, Sato Y, Kajita E, Fujita Y, Yura A, Kagamimori S.

J Bone Miner Metab. 2019 Aug 14. doi: 10.1007/s00774-019-01036-6. [Epub ahead of print] No abstract available.

PMID:
31414281
37.

Muraminomicins, new lipo-nucleoside antibiotics from Streptosporangium sp. SANK 60501-structure elucidations of muraminomicins and supply of the core component for derivatization.

Fujita Y, Kagoshima Y, Masuda T, Kizuka M, Ogawa Y, Endo S, Nishigoori H, Saito K, Takasugi K, Miura M, Murakami R, Muramatsu Y, Tokumitsu A, Koga T, Iizuka M, Aoyagi A, Suzuki T, Suzuki T, Suzuki Y, Ishida O, Nakahira T, Miyakoshi S, Konosu T, Takatsu T.

J Antibiot (Tokyo). 2019 Dec;72(12):943-955. doi: 10.1038/s41429-019-0215-7. Epub 2019 Aug 14.

PMID:
31413314
38.

The expression of gastrointestinal differentiation markers in extrahepatic cholangiocarcinoma: clinicopathological significance based on tumor location.

Ishida K, Osakabe M, Eizuka M, Tai S, Sugimoto R, Fujita Y, Katagiri H, Takahara T, Uesugi N, Nitta H, Sasaki A, Sugai T.

Hum Pathol. 2019 Aug 8;92:91-100. doi: 10.1016/j.humpath.2019.08.002. [Epub ahead of print]

39.

Risk Factors for Post-gastric Endoscopic Submucosal Dissection Bleeding with a Special Emphasis on Anticoagulant Therapy.

Toya Y, Endo M, Oizumi T, Akasaka R, Yanai S, Kawasaki K, Nakamura S, Eizuka M, Fujita Y, Uesugi N, Sugai T, Matsumoto T.

Dig Dis Sci. 2019 Aug 7. doi: 10.1007/s10620-019-05776-3. [Epub ahead of print]

PMID:
31392471
40.

Surfactants in glyphosate products in Japan.

Kamata H, Nakano S, Shima N, Fujita Y, Usui K, Kamijo Y, Hanazawa T, Katagi M.

Clin Toxicol (Phila). 2019 Aug 7:1-2. doi: 10.1080/15563650.2019.1648818. [Epub ahead of print] No abstract available.

PMID:
31389728
41.

Refractory Takayasu arteritis successfully treated with rituximab: case-based review.

Mutoh T, Ishii T, Shirai T, Akita K, Kamogawa Y, Fujita Y, Sato H, Shirota Y, Fujii H, Harigae H.

Rheumatol Int. 2019 Nov;39(11):1989-1994. doi: 10.1007/s00296-019-04390-w. Epub 2019 Aug 6. Review.

PMID:
31388749
42.

Aspects of a Large Tsunami That Struck the Sunda Strait in Indonesia: Lessons for Japan and the Rest of the World.

Inoue K, Takeshita H, Hashioka S, Takeichi N, Fujita Y.

Asia Pac J Public Health. 2019 Sep;31(6):574-575. doi: 10.1177/1010539519867220. Epub 2019 Aug 6. No abstract available.

PMID:
31387362
43.

Core-Muscle Training and Neuromuscular Control of the Lower Limb and Trunk.

Sasaki S, Tsuda E, Yamamoto Y, Maeda S, Kimura Y, Fujita Y, Ishibashi Y.

J Athl Train. 2019 Sep;54(9):959-969. doi: 10.4085/1062-6050-113-17. Epub 2019 Aug 6.

PMID:
31386583
44.

Flower power as human cancer cells compete with normal cells.

Fujita Y.

Nature. 2019 Aug;572(7768):181-182. doi: 10.1038/d41586-019-02161-y. No abstract available.

PMID:
31384049
46.

Parental factors predicting unnecessary ambulance use for their child with acute illness: A cross-sectional study.

Ueki S, Komai K, Ohashi K, Fujita Y, Kitao M, Fujiwara C.

J Adv Nurs. 2019 Jul 26. doi: 10.1111/jan.14161. [Epub ahead of print]

PMID:
31350761
47.

Increased Expression of Fibronectin Leucine-Rich Transmembrane Protein 3 in the Dorsal Root Ganglion Induces Neuropathic Pain in Rats.

Yamada M, Fujita Y, Hayano Y, Hayakawa H, Baba K, Mochizuki H, Yamashita T.

J Neurosci. 2019 Sep 18;39(38):7615-7627. doi: 10.1523/JNEUROSCI.0295-19.2019. Epub 2019 Jul 25.

PMID:
31346030
48.

Toward Quantitative Neurosurgical Guidance With High-Resolution Microscopy of 5-Aminolevulinic Acid-Induced Protoporphyrin IX.

Wei L, Fujita Y, Sanai N, Liu JTC.

Front Oncol. 2019 Jul 3;9:592. doi: 10.3389/fonc.2019.00592. eCollection 2019.

49.

Vasculo-Behçet disease complicated by conversion disorder diagnosed with 18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography (PET/CT).

Furuya MY, Temmoku J, Fujita Y, Matsuoka N, Asano T, Sato S, Kobayashi H, Watanabe H, Migita K.

Fukushima J Med Sci. 2019 Aug 30;65(2):55-60. doi: 10.5387/fms.2019-07. Epub 2019 Jul 20.

50.

Tumor-associated macrophage related interleukin-6 in cerebrospinal fluid as a prognostic marker for glioblastoma.

Hori T, Sasayama T, Tanaka K, Koma YI, Nishihara M, Tanaka H, Nakamizo S, Nagashima H, Maeyama M, Fujita Y, Yokozaki H, Hirose T, Kohmura E.

J Clin Neurosci. 2019 Oct;68:281-289. doi: 10.1016/j.jocn.2019.07.020. Epub 2019 Jul 18.

PMID:
31327593

Supplemental Content

Loading ...
Support Center